Enanta Pharmaceuticals (ENTA) EPS (Weighted Average and Diluted): 2012-2025
Historic EPS (Weighted Average and Diluted) for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to -$0.88.
- Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) rose 35.29% to -$0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.84, marking a year-over-year increase of 29.93%. This contributed to the annual value of -$3.84 for FY2025, which is 29.93% up from last year.
- Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$0.88 in Q3 2025, which was down 3.53% from -$0.85 recorded in Q2 2025.
- Over the past 5 years, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at -$0.85 during Q2 2025, and registered a low of -$1.86 during Q2 2023.
- In the last 3 years, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$1.33 in 2023 and averaged -$1.30.
- In the last 5 years, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 263.33% in 2021 and then soared by 42.47% in 2024.
- Quarterly analysis of 5 years shows Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$1.48 in 2021, then climbed by 6.08% to -$1.39 in 2022, then fell by 13.67% to -$1.58 in 2023, then surged by 33.54% to -$1.05 in 2024, then soared by 35.29% to -$0.88 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.88 for Q3 2025, versus -$0.85 for Q2 2025 and -$1.06 for Q1 2025.